Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 17, 1996

View Archived Issues

New antiplatelet agents described by Thomae

New imaging agents for 19F MRI claimed by Molecular Biosystems

Zeneca reports antiproliferative tyrosine kinase inhibitors

New diuretics reported by Pharmacia & Upjohn

Dual-action compounds claimed by British Biotech

Angiogenesis inhibitors under study at ADIR

More terazosin clinical data reported

SuperGen licenses metalloorganic compounds

Inactivation of SIV by LifeTECH's blood sterilization technology

Cortex notified of broad patent covering calpain inhibitors

Protein Polymer Technologies and Ethicon extend R&D collaboration

Rizatriptan goes head-to-head with sumatriptan in migraine patients

Method for treatment of CPVD available for licensing

Licensees sought for PKD1 gene and mutations

Oscillin and MAbs against it offered for licensing

NIH offers glycoprotein hormone superagonists for licensing

MRC offers Fv1 gene for licensing

Licenses offered for the use of IL-7 in increasing hematopoietic stem cells

Method of producing infectious RSV offered for licensing

CAK1 gene for treatment and diagnosis of cancers available for licensing

Glycine therapy as a potential new approach to schizophrenia Rx

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...